# HYMPAVZI

NDC: 0069-1510
Generic name: marstacimab-hncq
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20251016

FDA application: BLA761369

## Active ingredients

- MARSTACIMAB: 150 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-1510"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-1510
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2cc631e-13a6-40c2-acf9-065ccedfb90a